Journal of Multiple Sclerosis and Neuroimmunology

Contemporary Patterns of High-Efficacy Disease Modifying Therapy Use in Korean Patients with Relapsing-Remitting Multiple Sclerosis: Su-Hyun Kim, Na Young Park, Min Jeong Kim, Ki Hoon Kim, Jae-Won Hyun, Ho Jin Kim; J Mult Scler Neuroimmunol. 2023;14(2):99-105. Published online December 31, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.2.99; Full text PubReader ePub PDF

Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study: Su-Hyun Kim, Eun-Jae Lee, Ju-Hong Min, Sung-Min Kim, Ha Young Shin, Young Nam Kwon, Woojun Kim, Jeeyoung Oh, Jun Soon Kim, Seol-Hee Baek, In Soo Joo, Yoon-Ho Hong, Min Su Park, Eunhee Sohn, Tai-Seung Nam, Sun-Young Oh, So-Young Huh, Tae-Kyeong Lee, Jiwon Yang, Sunyoung Kim, Hung Youl Seok, Nam-Hee Kim, Jin-Hong Shin, Jeong Bin Bong, Soonwook Kwon, Seong-il Oh, Eunbin Cho, Hyun-June Shin, Hyung-Soo Lee, Kee Hong Park, Woo Kyung Kim, Jong Seok Bae, Ho Jin Kim; J Mult Scler Neuroimmunol. 2023;14(1):51-55. Published online June 30, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.1.51
Cited By 1; Full text PubReader ePub PDF

Cost Effectiveness of First-Line Rituximab in Koreans with Neuromyelitis Optica Spectrum Disorder: Jae-Won Hyun, Hyunmin Jang, Jeongmi Park, Min Young Lee, Su-Hyun Kim, Ho Jin Kim; J Mult Scler Neuroimmunol. 2020;11(2):53-58. Published online December 1, 2020; PDF

Multi-center Network of Multiple Sclerosis and Neuromyelitis Optical Spectrum Disorder in Korea: Results of the First Year Research: Hye Lim Lee, Jin Myoung Seok, Juhyeon Kim, Ho Jin Kim, Su-hyun Kim, Ha Young Shin, Byung-Jo Kim, Seol-Hee Baek, Sa-Yoon Kang, Sun-Young Oh, Seung-Han Lee, Ohyun Kwon, Kwang-Kuk Kim, Young-Min Lim, Sang-Soo Lee, Jeeyoung Oh, Eun bin Cho, Jin-Sung Park, Kyong Jin Shin, Sun-Young Kim, Jong Seok Bae, Kee Hong Park, So-Young Huh, Jong Kuk Kim, Byeol-A Yoon, Eun Hee Sohn, Joong-Yang Cho, Hye Jin Cho, Woojun Kim, Yoon-Ho Hong, Jae Young An, Dae Woong Bae, Hung Youl Seok, Sung-Min Kim, Seok Geun Han, Ju-Hong Min, Byoung Joon Kim; J Mult Scler Neuroimmunol. 2019;10(1):1-6. Published online March 1, 2019; PDF

Effectiveness of First-line Natalizumab Treatment in Patients with Highly Active Relapsing-remitting Multiple Sclerosis: Su-Hyun Kim, Ho Jin Kim; J Mult Scler Neuroimmunol. 2018;9(2):21-23. Published online September 1, 2018; PDF

Rituximab for the Treatment of Neuromyelitis Optica Spectrum Disorder: Su-Hyun Kim, Jae-Won Hyun, Ho Jin Kim; J Mult Scler Neuroimmunol. 2017;8(1):1-8. Published online March 1, 2017; PDF

Clinical Practice Guideline of Clinically Isolated Syndrome: Part II. Management and Monitoring: Jeeyoung Oh, Joong-Yang Cho, Sa Yoon Kang, Nam-Hee Kim, Sun-Young Kim, Sung-Min Kim, Su-Hyun Kim, Jee Young Kim, Tai-seung Nam, Min Su Park, Ha Young Shin, Jung Hee Cho, So-Young Huh, Woojun Kim, Ju-Hong Min, Ohyun Kwon; J Mult Scler Neuroimmunol. 2016;7(2):40-48. Published online September 1, 2016; PDF

Clinical Practice Guideline of Clinically Isolated Syndrome: Part I. Evaluation and Diagnosis: Su-Hyun Kim, Min Su Park, Sa Yoon Kang, Nam-Hee Kim, Sun-Young Kim, Sung-Min Kim, Jee Young Kim, Tai-seung Nam, Ju-Hong Min, Ha Young Shin, Jeeyoung Oh, Jung Hee Cho, Joong-Yang Cho, So-Young Huh, Woojun Kim, Ohyun Kwon; J Mult Scler Neuroimmunol. 2016;7(2):29-39. Published online September 1, 2016; PDF

Neutralizing Antibodies in Korean Multiple Sclerosis Patients Treated with Interferon-Beta: Preliminary Study: Jae-Won Hyun, Byungsoo Kong, AeRan Joung, In Hye Jeong, Su-Hyun Kim, Ho Jin Kim; J Mult Scler Neuroimmunol. 2016;7(1):9-13. Published online March 1, 2016; PDF

Significant Improvement of Spasticity with Intrathecal Baclofen Pump Implantation in a Patient with Multiple Sclerosis: Jae-Won Hyun, Su-Hyun Kim, In Hye Jeong, Jae-Hyun Kim, Dae Hyun Kim, Ho Jin Kim; J Mult Scler Neuroimmunol. 2015;6(2):40-43. Published online September 1, 2015; PDF

Healthcare Costs of Multiple Sclerosis in Korea According to the Level of Disability: Jae-Won Hyun, Jae-Won Hyun, AeRan Joung, AeRan Joung, In Hye Jeong, In Hye Jeong, Su-Hyun Kim, Su-Hyun Kim, Ho Jin Kim, Ho Jin Kim; J Mult Scler Neuroimmunol. 2015;6(1):9-13. Published online March 1, 2015

The Strategy of Treatment of Neuromyelitis Optica Spectrum Disorder: So-young Huh, So-young Huh, Su-Hyun Kim, Su-Hyun Kim, Ho Jin Kim, Ho Jin Kim; J Mult Scler Neuroimmunol. 2015;6(1):1-8. Published online March 1, 2015

Cerebral Adrenomyeloneuropathy Clinically Mimicking Primary Progressive Multiple Sclerosis: Jae-Won Hyun, Jae-Won Hyun, Su-Hyun Kim, Su-Hyun Kim, Sang-Hyun Hwang, Sang-Hyun Hwang, Ho Jin Kim, Ho Jin Kim; J Mult Scler Neuroimmunol. 2014;5(1):22-24. Published online March 1, 2014

Current Treatment Approaches for Neuromyelitis Optica: Su-Hyun Kim, Woojun Kim, Ho Jin Kim; J Mult Scler Neuroimmunol. 2011;2(2):45-51. Published online September 1, 2011; PDF

Early Diagnosis and Treatment of Multiple Sclerosis: Su-Hyun Kim, Woojun Kim, Ho Jin Kim; J Mult Scler Neuroimmunol. 2010;1(2):44-51. Published online September 1, 2010

4,835	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
1,441	Rituximab Treatment for Neuroimmunologic Disorders
1,322	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
1,130	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
1,021	New Therapeutic Agents in Myasthenia Gravis

Search